IDE and diabetes mellitus: Nevertheless, Mirsky and colleagues utilized these and other functionally characterized IDE inhibitors to test the idea that inhibition of IDE might prove to be an alternative way to treat diabetes—namely, by preventing the breakdown of endogenous insulin rather than supplementing with injection of exogenous insulin.